With its acquisition of Maine Biotechnology Services, BBI Solutions has added more than 80 new antibodies to its growing product portfolio, as well as custom antibody development services.
Read More
Siemens Healthineers has received FDA premarket notification clearance for its blood urea nitrogen and total carbon dioxide point-of-care tests to aid in the diagnosis of renal diseases and metabolic imbalances.
Read More
As part of its breakthrough devices program, FDA reviewed and authorized for marketing the Banyan Brain Trauma Indicator from Banyan Biomarkers in less than 6 months.
Read MorePromoted as a complete sample-to-insight solution, the Qiagen GeneReader NGS system comprises all elements of an NGS workflow.
Read More
Presenting an evaluation of the GeneReader next-generation sequencing (NGS) system, the article assesses the performance of the system in comparison with an alternative NGS technology.
Read More